AskRobots

Search results for “site:ncbi.nlm.nih.gov”

Page 38 of about 437 results

ncbi.nlm.nih.gov pubmed › 33723282

Countrywide population movement monitoring using mobile devices generated (big) data during the COVID-19 crisis

Mobile phones have been used to monitor mobility changes during the COVID-19 pandemic but surprisingly few studies addressed in detail the implementation of practical applications involving whole populations. We report a method of...

Quality not rated yet Government About this page ›
Save
ncbi.nlm.nih.gov pubmed › 33750252

One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms

Prospective Register of Systematic Reviews (PROSPERO); registration number CRD42020227038).

Quality not rated yet Government About this page ›
Save
ncbi.nlm.nih.gov pubmed › 33755688

Magnitude of asymptomatic COVID-19 cases throughout the course of infection: A systematic review and meta-analysis

In conclusion, one-fourth of SARS-CoV-2 infections are remained asymptomatic throughout the course infection. Scale-up of testing, which targeting high risk populations is recommended to tackle the pandemic.

Quality not rated yet Government About this page ›
Save
ncbi.nlm.nih.gov pubmed › 33763271

Transitory Fetal Skin Edema in a Pregnant Patient with a Mild SARS-CoV-2 Infection

Women who have undergone SARS-CoV-2 infection during pregnancy should receive a subsequent appropriate follow-up in order to clarify the fetal consequences of the novel coronavirus, if any.

Quality not rated yet Government About this page ›
Save
ncbi.nlm.nih.gov pubmed › 33806100

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)

In the last two decades, three unknown pathogens have caused outbreaks, generating severe global health concerns. In 2003, after nucleic acid genotyping, a new virus was named severe acute respiratory syndrome coronavirus (SARS-CoV). After...

Quality not rated yet Government About this page ›
Save
ncbi.nlm.nih.gov pubmed › 33835769

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Vaccination with ChAdOx1 nCov-19 can result in the rare development of immune thrombotic thrombocytopenia mediated by platelet-activating antibodies against PF4, which clinically mimics autoimmune heparin-induced thrombocytopenia. (Funded by the German Research Foundation.).

Quality not rated yet Government About this page ›
Save

Try “site:ncbi.nlm.nih.gov” on: Marginalia · Mojeek · Wiby · DuckDuckGo · Bing · Google · Wikipedia · Internet Archive